Author

Adrian Paul

Observed name: Paul, Adrian

Institution: Heidelberg University

Observed institutions: Heidelberg University, University Hospital Heidelberg

OpenAlex ID: A5045752899

Use of Tissue Specimens from Stereotactic Biopsies for Patient-Derived GBM Organoid-Based Drug Testing

2025 · Amélie Wöllner, Adrian Paul, et al. · Cells · 4

Automated and personalized glioblastoma tumor organoid drug screening platform exposes sensitivity to proteasome and HDAC inhibitors

2026 · Gerhard Jungwirth, Adrian Paul, et al. · npj Precision Oncology · 1

Modl-04. Establishment of a Reliable Glioblastoma Tumor-organoid Platform Enables Automated High-throughput Drug Screening Advancing Personalized Medicine

2022 · Christel Herold-Mende, Adrian Paul, et al. · Neuro-Oncology · 1

Dddr-22. Use of Biopsy-derived Tumor Organoids for Personalized Drug Testing in Recurrent Glioblastoma

2024 · Christel Herold-Mende, Amelie Woellner, et al. · Neuro-Oncology

Ddre-42. Towards Precision Medicine: Automated Drug Screening Platform Utilizing Tumor-organoids to Identify Patient-specific Drug-responses in Meningioma

2021 · Gerhard Jungwirth, Adrian Paul, et al. · Neuro-Oncology

Works count: 7

Citation count: 6

H-index: 1

I10-index: